Fig. 1From: Effect-site concentration of propofol required for LMA-Supreme™ insertion with and without remifentanil: a randomized controlled trialFlow-diagram of patient progress through the phases of the trial. Patients were recruited until a sample size of seven crossovers was reached in each groupBack to article page